Supresión del cáncer de páncreas y aumento de las tasas de supervivencia en animales a los que se les implantaron células de cáncer de páncreas humano cuando se trataron con el agente biológico BGX, una terapia dirigida patentada desarrollada internamente por BioGate TAIPEI, 7 de marzo de…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.